Expertise in
28
conditions

Dr. Lucybeth Nieves-Arriba

Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Novant Health Medical Group Coastal Region LLC
2131 S 17th St, 
Wilmington, NC 
Accepting New Patients
Offers Telehealth
Expertise in
28
conditions
Novant Health Medical Group Coastal Region LLC
2131 S 17th St, 
Wilmington, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Lucybeth Nieves-Arriba is a Gynecologic Oncologist and an Oncologist in Wilmington, North Carolina. Dr. Nieves-Arriba is highly rated in 28 conditions, according to our data. Their top areas of expertise are Endometrial Cancer, Endometrial Stromal Sarcoma, Ovarian Cysts, Bladder Reconstruction, and Gastrostomy. Dr. Nieves-Arriba is currently accepting new patients.

Their clinical research consists of co-authoring 2 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gynecologic Oncology
Oncology
Obstetrics and Gynecology
Licenses
Obstetrics & Gynecology in NC
Hospital Affiliations
Novant Health Brunswick Medical Center
Novant Health New Hanover Regional Medical Center
Languages Spoken
English

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

NOVANT HEALTH MEDICAL GROUP COASTAL REGION LLC
2131 S 17th St, Wilmington, NC 28401

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Prospective Observational Cohort Study to Develop a Predictive Model of Taxane-Induced Peripheral Neuropathy in Cancer Patients
A Prospective Observational Cohort Study to Develop a Predictive Model of Taxane-Induced Peripheral Neuropathy in Cancer Patients
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2025
Intervention Type: Other, Drug
A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin, CTEP-Supplied Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin and CTEP-Supplied Bevacizumab in Platinum Resistant Ovarian Cancer
A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin, CTEP-Supplied Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin and CTEP-Supplied Bevacizumab in Platinum Resistant Ovarian Cancer
Enrollment Status: Active_not_recruiting
Publish Date: March 30, 2025
Intervention Type: Other, Procedure, Drug, Biological
Study Drugs: Atezolizumab, Bevacizumab, Pegylated liposomal doxorubicin hydrochloride
Study Phase: Phase 2/Phase 3
A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475, NSC #776864) in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer
A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475, NSC #776864) in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer
Enrollment Status: Active_not_recruiting
Publish Date: March 18, 2025
Intervention Type: Other, Drug, Procedure, Biological
Study Drugs: Carboplatin, Paclitaxel, Pembrolizumab
Study Phase: Phase 3
A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
Enrollment Status: Active_not_recruiting
Publish Date: July 16, 2024
Intervention Type: Procedure, Drug, Other
Study Drugs: Cediranib, Cediranib Maleate, Olaparib, Paclitaxel, Pegylated Liposomal Doxorubicin Hydrochloride, Topotecan, Topotecan Hydrochloride
Study Phase: Phase 2/Phase 3
View 3 Less Clinical Trials

2 Total Publications

Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection.
Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: January 22, 2013
Similar Doctors
Expertise in
22
conditions
Dr. Walter H. Gajewski
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Expertise in
22
conditions
Dr. Walter H. Gajewski
Gynecologic Oncology | Oncology | Obstetrics and Gynecology

Novant Health Medical Group Coastal Region LLC

2131 S 17th St, 
Wilmington, NC 
 (0.1 mi)
910-667-3000
Experience:
43+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Walter Gajewski is a Gynecologic Oncologist and an Oncologist in Wilmington, North Carolina. Dr. Gajewski has been practicing medicine for over 43 years is highly rated in 22 conditions, according to our data. His top areas of expertise are Virilizing Ovarian Tumor, Ovarian Carcinosarcoma, Malignant Mixed Mullerian Tumor, Ovarian Cancer, and Bladder Reconstruction. Dr. Gajewski is currently accepting new patients.

Expertise in
21
conditions
Dr. John M. Robinson
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Expertise in
21
conditions
Dr. John M. Robinson
Gynecologic Oncology | Oncology | Obstetrics and Gynecology

Novant Health Medical Group Coastal Region LLC

2131 S 17th St, 
Wilmington, NC 
 (0.1 mi)
910-662-9300
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

John Robinson is a Gynecologic Oncologist and an Oncologist in Wilmington, North Carolina. Dr. Robinson is highly rated in 21 conditions, according to our data. His top areas of expertise are Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Cervical Cancer, Neuroendocrine Carcinoma of the Cervix, and Bladder Reconstruction. Dr. Robinson is currently accepting new patients.

Expertise in
29
conditions
Dr. David A. Rizzieri
Oncology | Transplant Surgery | Infectious Disease
Expertise in
29
conditions
Dr. David A. Rizzieri
Oncology | Transplant Surgery | Infectious Disease

Novant Health Medical Group Coastal Region LLC

2131 S 17th St, 
Wilmington, NC 
 (0.1 mi)
910-667-3000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

David Rizzieri is an Oncologist and a Transplant Surgeon in Wilmington, North Carolina. Dr. Rizzieri is highly rated in 29 conditions, according to our data. His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Rizzieri is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nieves-Arriba's expertise for a condition
ConditionClose
    View All 15 Distinguished Conditions
    View All 13 Advanced Conditions
    View All 30 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile